Deere beats earnings estimates (again). The stock is going up. Share this:FacebookX Related Post navigation Agilent Considers Appealing CRISPR-Related Patent Dispute With Synthego Jefferies keeps Zentalis Pharma a ‘buy’ with a $70.00 price target